Form 4: Universal Health Services CEO Marc D. Miller Reports Stock Transactions

Marc D. Miller, President and CEO of Universal Health Services, reports acquisition and disposal of Class B Common Stock due to vesting of performance-based restricted stock units and tax withholding.

Summary

• On March 12, 2025, Marc D. Miller, the President and CEO of Universal Health Services Inc. [UHS], acquired 49,587 shares of Class B Common Stock upon the vesting of performance-based restricted stock units (RSUs).
• These RSUs were awarded on March 23, 2022, and vested based on the issuer's satisfaction of certain performance criteria.
• Concurrently, Miller disposed of 21,070 shares of Class B Common Stock at a price of $166.61 per share.
• Following these transactions, Miller directly owns 252,395 shares of Class B Common Stock.
• Miller also has indirect ownership through various trusts and LLCs, including AMK 2014 LLC, MDM 2014 LLC, MS 2014 LLC, The Abby Danielle Miller 2002 Trust, The Abby Miller King 2011 Family Trust, The Marc Daniel Miller 2002 Trust, The Marc Daniel Miller 2011 Family Trust, The Marni Spencer 2002 Trust and The Marni Spencer 2011 Family Trust.
• The report was filed on March 14, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The vesting of RSUs indicates the company met performance targets, but the subsequent sale of shares introduces a slightly negative element, although it's likely tax-related.

Positives

• The vesting of performance-based restricted stock units suggests that Universal Health Services met certain performance criteria, which could be viewed positively.

Negatives

• The disposal of 21,070 shares could be interpreted negatively, although it is likely related to tax obligations from the vesting of the RSUs.

Risks

• The document does not explicitly mention any risks.
• However, insider selling, even for tax purposes, can sometimes be perceived negatively by the market.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's future prospects.

Comparison to Industry Standards

• Form 4 filings are standard practice across publicly traded companies, including competitors like HCA Healthcare (HCA) and Tenet Healthcare (THC).
• The vesting of RSUs based on performance criteria is a common compensation strategy to align management's interests with those of shareholders.
• The tax-related selling of shares after vesting is also a typical occurrence among executives.

Stakeholder Impact

• The vesting of RSUs and subsequent stock transactions could have a minor impact on shareholders, potentially influencing the stock price in the short term.
• The transactions do not appear to have a significant impact on employees, customers, suppliers, or creditors.

Key Dates